CALR and myeloproliferative disorder: At baseline, αIIbβ3 and GPIb expressions were significantly reduced in blood platelets from patients with CALR+ and JAK2V617F+, without difference between blood platelets from patients with CALR+ and JAK2V617F+ MPN (Figure 1B).